Effect of reduced agalsidase Beta dosage in fabry patients: the Australian experience
about
Effect of reduced agalsidase Beta dosage in fabry patients: the Australian experience
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Effect of reduced agalsidase Beta dosage in fabry patients: the Australian experience
@ast
Effect of reduced agalsidase Beta dosage in fabry patients: the Australian experience
@en
type
label
Effect of reduced agalsidase Beta dosage in fabry patients: the Australian experience
@ast
Effect of reduced agalsidase Beta dosage in fabry patients: the Australian experience
@en
prefLabel
Effect of reduced agalsidase Beta dosage in fabry patients: the Australian experience
@ast
Effect of reduced agalsidase Beta dosage in fabry patients: the Australian experience
@en
P2093
P2860
P356
P1476
Effect of reduced agalsidase Beta dosage in fabry patients: the Australian experience
@en
P2093
Australian State Fabry Disease Treatment Centres
Charles Denaro
David Sillence
Ian Chapman
Jack Goldblatt
Janice Fletcher
Joanna Ghali
Mark Thomas
P2860
P356
10.1007/8904_2011_44
P50
P577
2011-09-15T00:00:00Z